Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions. Read More
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday. ...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. ...
With the sudden increase of cases during the second wave of the pandemic, the government has taken swift actions to enhance the availability of an anti-viral drug Remdesivir across the country. Presently, nearly 119 lakh vials of Remdesivir are being ...
US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients. ...
India Ratings and Research (Ind-Ra) has said the 10.3 per cent year-on-year growth of India's pharmaceutical market during March was led by volume growth of 1.6 per cent, price growth of 5.1 per cent and products launches at 3.6 per cent. ...
